#China #Shanghai #oncology #healthcare services #Zhongchao Inc.

Zhongchao Inc. Raises $5 Million in Public Offering

On May 29, 2026, Zhongchao Inc. (NASDAQ: ZCMD), a prominent internet technology platform dedicated to providing essential services for patients battling cancer and other critical illnesses, announced a successful pricing of its best efforts public offering. The offering, projected to yield approximately $5 million in gross revenue for the company, is a significant step towards enhancing healthcare services it provides.

Details of the Offering

This offering involves a total of 9,259,260 units, each unit comprising of one Class A ordinary share valued at $0.008, and a warrant for the purchase of one Class A ordinary share. The public offering price is set at $0.54 per unit, enabling investors to participate at an accessible price point. Furthermore, the pre-funded warrants, which will be available for immediate issuance, are designed to encourage greater participation from investors, facilitating quicker access to the company’s shares.

The warrants are set with an initial exercise price of $0.594 per share and can be exercised starting on the issuance date, with a window extending six months thereafter. Initial shares are expected to separate from the warrants symbolically, providing flexibility for investors during this financial undertaking.

Closing and Additional Options

The anticipated closing for this public offering is around June 1, 2026, contingent upon standard closing conditions being met. Notably, purchasers of the offering have the option to acquire additional units within 30 days post-closing, potentially doubling their investment at the selling price of the original offering. This strategic provision could enhance investor interest significantly.

Univest Securities, LLC is serving as the sole placement agent for this public offering, ensuring adherence to regulatory standards and facilitating the transaction efficiently.

Company Overview

Zhongchao Inc. operates as an offshore holding company, with its base in the Cayman Islands, and consolidates financial results from its main operating entities situated in China. These entities specialize in a variety of online healthcare services, including education and training for healthcare professionals via the "MDMOOC" platform, patient management for oncology, and general health discussions through the "Sunshine Health Forums." This diverse range allows Zhongchao to address significant public health needs effectively.

The company’s solid digital infrastructure positions it well for continuous growth in a sector that is increasingly leaning towards online solutions. As healthcare demands rise globally, the investment attracted by Zhongchao will support further developments in its service offerings and technology advancements.

Future Outlook

The recent offering illustrates Zhongchao's proactive approach to funding the expansion of its healthcare solutions. By investing in technology and service enhancements, the company is poised to navigate the complexities of the healthcare landscape while continuing to provide valuable services for patients facing dire health challenges.
Investors are advised to keep an eye on the developments from Zhongchao, as the outcomes from this offering could pave the way for future initiatives and expansions within the company. Furthermore, the attention to understanding investor sentiment and market conditions will remain essential for the company's sustained growth in the public offerings space.

For more details on Zhongchao and their latest developments, potential investors can visit their official investor relations site at izcmd.com. This ongoing commitment to transparency and engagement establishes Zhongchao as a formidable player in the healthcare technology industry.

Zhongchao aims to leverage its strategic offerings to position itself as a leading platform catering to the healthcare sector, ensuring that support is readily available for those impacted by critical illnesses.